FEBUXOSTAT METHYL ESTER (25 mg) (Methyl 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylate )

In Stock
Ready to ship

Catalogue No.

1A20360

CAS No.

923942-34-1

Molecular Formula

C17H18N2O3S

Product Type

Pharmaceutical Analytical Impurities

$550.00

Quantity

Click Here to learn more about Pharmaceutical Analytical Impurities (PAI). PAI products are different from official USP Reference Standards. This material is an Analytical Material and not a USP Reference Standard.

Additional information

Current Lot Information

Current Lot:

F30040

CAS RN®

923942-34-1

Harmonized System (HS) Code *:

29341000

UN No:

N/A

NDC No:

N/A

Molecular Formula

C17H18N2O3S

Container Type:

VIAL

Base Control Substance (substance %):

N | A

Product Information

SDS: Safety data sheet.pdf

USP Certificates/Product Information Sheets and Valid Use Dates

Lot No

USP Certificates/Product Information Sheets and Valid Use Dates

Valid Use Date

Country of Origin*

Material Origin*

F30040

1A20360-F30040

See Product Information Sheet

India

Chemical Synthesis

Lot No

F30040

USP Certificates/Product Information Sheets and Valid Use Dates

1A20360-F30040

Valid Use Date

See Product Information Sheet

Country of Origin*

India

Material Origin*

Chemical Synthesis

Frequently bought together

FEBUXOSTAT METHYL ESTER (25 mg) (Methyl 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylate  )

Catalogue No.

1A20360

CAS No.

923942-34-1

Molecular Formula

C17H18N2O3S

Product Type

Pharmaceutical Analytical Impurities

PROPAFENONE GLYCIDYL ANALOG

Catalogue No.

1A09950

CAS No.

22525-95-7

Molecular Formula

C18H18O3

Product Type

Pharmaceutical Analytical Impurities

DICLOFENAC ACETAMIDE

Catalogue No.

1A10360

CAS No.

560075-65-2

Molecular Formula

C14H10Cl3NO

Product Type

Pharmaceutical Analytical Impurities